Sign in
4

Changes in Ownership

KALA BIO, Inc. Filed Acc 0001179110-17-010599

Options or other derivatives

  • Chief Scientific Officer acquired 28,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Chen Hongming · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-07-19 Grant or award : show line 1 in the form Stock Option (right to buy) +28,800 $15.00 2027-07-18 28,800 28,800 D
Loading xslF345X03/edgar.xml…